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Abstract
Background: frailty is an especially problematic expression of population ageing. International guidelines recommend routine
identiﬁcation of frailty to provide evidence-based treatment, but currently available tools require additional resource.
Objectives: to develop and validate an electronic frailty index (eFI) using routinely available primary care electronic health record data.
Study design and setting: retrospective cohort study. Development and internal validation cohorts were established using a ran-
domly split sample of the ResearchOne primary care database. External validation cohort established using THIN database.
Participants: patients aged 65–95, registered with a ResearchOne or THIN practice on 14 October 2008.
Predictors: we constructed the eFI using the cumulative deﬁcit frailty model as our theoretical framework. The eFI score is
calculated by the presence or absence of individual deﬁcits as a proportion of the total possible. Categories of ﬁt, mild, moder-
ate and severe frailty were deﬁned using population quartiles.
Outcomes: outcomes were 1-, 3- and 5-year mortality, hospitalisation and nursing home admission.
Statistical analysis: hazard ratios (HRs) were estimated using bivariate and multivariate Cox regression analyses. Discrimination
was assessed using receiver operating characteristic (ROC) curves. Calibration was assessed using pseudo-R2 estimates.
Results: we include data from a total of 931,541 patients. The eFI incorporates 36 deﬁcits constructed using 2,171 CTV3
codes. One-year adjusted HR for mortality was 1.92 (95% CI 1.81–2.04) for mild frailty, 3.10 (95% CI 2.91–3.31) for moderate
frailty and 4.52 (95% CI 4.16–4.91) for severe frailty. Corresponding estimates for hospitalisation were 1.93 (95% CI 1.86–
2.01), 3.04 (95% CI 2.90–3.19) and 4.73 (95% CI 4.43–5.06) and for nursing home admission were 1.89 (95% CI 1.63–2.15),
3.19 (95% CI 2.73–3.73) and 4.76 (95% CI 3.92–5.77), with good to moderate discrimination but low calibration estimates.
Conclusions: the eFI uses routine data to identify older people with mild, moderate and severe frailty, with robust predictive
validity for outcomes of mortality, hospitalisation and nursing home admission. Routine implementation of the eFI could
enable delivery of evidence-based interventions to improve outcomes for this vulnerable group.
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Background
Frailty is an especially problematic expression of population
ageing. It is a condition characterised by loss of biological
reserves across multiple organ systems and vulnerability to
physiological decompensation after a stressor event [1].
Older people with frailty are at increased risk of adverse out-
comes including disability, hospitalisation, nursing home ad-
mission and mortality [2, 3].
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There is evidence that frailty may be modiﬁable and it is
considered to have greater reversibility than disability [1, 4].
The UK and international consensus guidance has recom-
mended identiﬁcation of frailty as part of routine clinical
encounters, or wider population screening, to facilitate the
planning and delivery of services for older people [5, 6].
However, there are several current obstacles to these recom-
mendations, including additional clinical resource required
and inaccuracy of simple tools [7].
The cumulative deﬁcit model identiﬁes frailty on the basis
of a range of variables that include symptoms, signs, diseases,
disabilities and abnormal laboratory values, collectively re-
ferred to as deﬁcits [8]. The original model was based on 92
variables, but subsequent work has shown that this can be
reduced to a more manageable 30 or so without loss of pre-
dictive validity [9]. The variables can be used to calculate a
frailty index (FI) score, which is a simple calculation of the
presence or absence of each variable as a proportion of the
total. The core criteria for variable inclusion into the FI are:
(i) biologically plausible; (ii) accumulates with age; and (iii)
does not saturate too early (i.e. the prevalence of the deﬁcit
does not reach 100% before older age) [10]. This makes the
FI very adaptable as a conceptual approach.
Primary care EHR systems in the UK use Read codes to
categorise and log multiple patient characteristics, including
symptoms, signs, laboratory test results, diseases, disabilities
and information about social circumstances [11]. Similar
coding schemes (IPCP and ICD-10) are used in primary care
EHR systems in other countries [12]. EHR systems therefore
provide a potentially simple yet powerful mechanism for
identifying cumulative deﬁcits to recognise and grade the se-
verity of frailty as part of routine care.
Objectives
The objective of this study was to develop and validate an
electronic frailty index (eFI) that is automatically populated
from routinely collected data contained within the primary
care EHR.
Methods
Study design
We conducted a retrospective cohort study using anonymised
primary care electronic health record data contained in the
ResearchOne [13] and The Health Improvement Network
(THIN) [14] databases from 14 October 2008 to 14 October
2013.
ResearchOne is a health and care research database con-
sisting of de-identiﬁed clinical and administrative data drawn
from the electronic health records of around six million
patients currently held on the TPP SystmOne clinical system
[15]. The THIN database contains longitudinal anonymised
EHRs from over 500 UK primary care practices using
the Vision clinical computer system [16] and has linked sec-
ondary care data for approximately 160 of these practices.
We used the ResearchOne database to establish development
and internal validation cohorts using a randomly split sample
approach. We then used the THIN database to establish an
independent external validation cohort.
Participants
Patients aged 65–95 years and registered at a ResearchOne or
THIN practice on 14 October 2008 were eligible. Patients
not permanently registered at the practice were excluded.
Development cohort
We used the cumulative deﬁcit model of frailty as our theoretic-
al framework. We followed published guidance on creating an
FI using the cumulative deﬁcit model in a randomly split
sample of the ResearchOne database [10]. As previous frailty
indexes have been validated using non-weighted methods [8],
our approach to development of the eFI was based on im-
proper linear modelling techniques, whereby the weights of the
predictor variables were assumed to be equal [17].
We ran a series of searches to identify Clinical Terms
Version 3 (CTV3) Read codes for inclusion. The ﬁrst search
used terms based on the Canadian Study of Health and
Aging (CSHA) FI [18] to identify potential text and numeric
codes. We then ran a second search by calculating regression
coefﬁcients for code prevalence against increasing age
between 65 and 95 years to identify individual codes that in-
crease in prevalence with age.
Two independent researchers then hand searched all poten-
tial codes to identify those with face validity for inclusion.
Codes were then categorised by an organ system to ensure a
range of deﬁcits were considered, consistent with the cumula-
tive decline in multiple physiological systems that characterises
frailty [1]. Codes identifying physical disability and social vulner-
ability were categorised separately. Any disagreements were
settled by consensus. Cut-points for numeric data were deﬁned
by reported laboratory reference ranges and international stand-
ard diagnostic criteria. An expert frailty panel then constructed
the eFI by grouping codes into deﬁcits to ensure that the ﬁrst
criterion for inclusion (biologically plausible) was met [10].
Prevalence of putative deﬁcits was plotted against age and
linear regression coefﬁcients and r2 values were calculated.
To ensure that the second criterion for inclusion (increased
prevalence with age) was met, only deﬁcits with a population
prevalence >0.5%, a positive regression coefﬁcient and an r2
value of >0.30 were included. To satisfy the third criterion
for inclusion (does not saturate too early), deﬁcits that
reached 100% prevalence by age 65 were excluded.
Categories of ﬁt, mild frailty, moderate frailty and severe
frailty were deﬁned by eFI quartiles using the 99th centile as the
upper limit.
Internal validation cohort
Validation of the eFI was by investigation of predictive valid-
ity as a method of criterion validation and the measure of
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primary clinical interest in frailty. The main outcomes of
interest were: (i) all-cause mortality; (ii) unplanned hospital-
isation; and (iii) nursing home admission. All-cause mortality
was identiﬁed by date of death, which is reliably recorded in
the electronic health record; practices were included after the
date of acceptable mortality recording [19]. Unplanned hos-
pitalisation was identiﬁed using coded evidence of a hospital
admission/discharge (using Read codes or outcome ﬁeld in
medical ﬁle). Nursing home admission was identiﬁed using
Read coded evidence of nursing home admission, or by
change of residence to nursing home address, using the Care
Quality Commission list of registered UK nursing homes.
Hazard ratios (HRs) at 1, 3 and 5 years were estimated for
outcomes of mortality, hospitalisation and nursing home ad-
mission using bivariate and multivariate Cox regression ana-
lyses, with the eFI as the independent variable and age and
gender as covariates.
We assessed for discrimination using receiver operating
characteristic (ROC) curves to estimate areas under the
curve (AUC) and associated c statistics for the eFI for
mortality, unplanned hospitalisation and nursing home ad-
mission at 1, 3 and 5 years. To assess how much variability
in these outcomes (mortality, hospitalisation, nursing home
admission) was explained by the eFI, we tested calibration
using pseudo-R2 estimates. Higher values indicate more
variation is explained. We used R (version 3.0.2) [20] for all
analyses.
External validation cohort
The individual eFI deﬁcits (predictors) of interest were
mapped from CTV3 (used in SystmOne/ResearchOne prac-
tices) to Read version 2 (used in Vision/THIN practices)
using a standard mapping table, available from the
Technology Reference data Update Distribution website [21],
and validated by researchers and clinicians with expertise in
clinical coding.
HRs at 1, 3 and 5 years were estimated for the outcome
of mortality using bivariate and multivariate Cox regression
analyses, with the eFI as the independent variable and age
and gender as covariates. In THIN, hospitalisation was iden-
tiﬁed by linked hospital data using the Hospital Episode
Statistics (HES) database, which records UK information on
hospital admissions, outpatient appointments and Accident
& Emergency Department attendances. One- and 3-year
HRs were estimated for the outcome of hospitalisation using
HES linked data, measured between 14 October 2008 and
30 March 2012. It was not possible to estimate 5-year HRs,
because there is a delay to routine data linkage between HES
and THIN. Admission rates per 1,000 person-years and
bed-days per admission for those identiﬁed as ﬁt, mild frailty,
moderate frailty and severe frailty were also estimated. It was
not possible to identify nursing home admission in THIN.
We assessed for discrimination using ROC curves and
associated c statistics for the eFI for mortality at 1, 3 and 5
years, and hospitalisation at 1 and 3 years. We tested eFI cali-
bration using pseudo-R2 estimates for these timepoints. We
used Stata (version 12) for analysis of the external validation
cohort [22].
Results
Anonymised data from a total of 931,541 patients aged 65–
95 were included (207,814 in the development cohort,
207,720 in the internal validation cohort, 516,007 in the ex-
ternal validation cohort). A total of 213,064 patients in the
external validation cohort had HES linkage for the estima-
tion of hospitalisation, admission rates and bed-day usage.
Baseline characteristics for the development, internal val-
idation and external validation cohorts are presented
(Table 1). The mean eFI score was 0.14 (SD 0.09) for the de-
velopment and internal validation cohorts and 0.15 (SD
0.10) for the external validation cohort. The mean eFI score
was slightly higher for females in all three cohorts (see
Table 1) and increased with age for both females and males.
There was a right-skewed population distribution to the
eFI in all three cohorts, consistent with the usual FI distribu-
tion reported in epidemiological studies (Supplementary
data, Figure S1, available in Age and Ageing online). There was
a negative correlation between the eFI and social deprivation,
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Table 1. Baseline characteristics
Characteristic Development
cohort
(n= 207,814)
Internal
validation cohort
(n= 207,720)
External
validation cohort
(n= 516,007)
Age (years) 75.0 (7.2) 75.0 (7.3) 75.0 (7.3)
Gender
Male 45% 45% 44%
Female 55% 55% 56%
FI score: mean (SD) 0.14 (0.09) 0.14 (0.09) 0.15 (0.10)
Males: mean (SD) 0.13 (0.09) 0.13 (0.09) 0.14 (0.10)
Females: mean (SD) 0.15 (0.10) 0.15 (0.10) 0.16 (0.10)
FI score 99th centile 0.49 0.49 0.42
Frailty categorya
Fit 50% 50% 43%
Mild 35% 35% 37%
Moderate 12% 12% 16%
Severe 3% 3% 4%
Number of
comorbidities
2.1 (1.2) 2.2 (1.1) 2.3 (1.3)
Number of
medications
8 (8.0) 8 (8.1) 9 (6.8)
Townsend quintile (social deprivation)b
1 (least deprived) 28% 28% 27%
2 18% 18% 24%
3 23% 23% 20%
4 16% 16% 16%
5 15% 15% 11%
All values are mean (SD) unless otherwise stated. Comorbidities defined using
Health Survey for England definition (cardiovascular disease; diabetes; cancer;
chronic lung disease; asthma; arthritis; osteoporosis; Parkinson’s disease; any
emotional, nervous or psychiatric disease).
FI, frailty index.
aFI scores of 0–0.12 = fit; >0.12–0.24 =mild frailty; >0.24–0.36 =moderate
frailty; >0.36 = severe frailty.
b2% missing data on social deprivation in external validation cohort.
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measured using the index of nultiple deprivation (IMD)
(Supplementary data, Figure S2, available in Age and Ageing
online).
Development cohort
Thirty-six deﬁcits, constructed using 2,171 CTV3 codes, met
our inclusion criteria (Box 1). Polypharmacy was deﬁned on
the basis of the presence of ≥5 prescribed medications, using
chapters 1–15 of the British National Formulary.
The prevalence of individual deﬁcits is presented in
Supplementary data, Table S2, available in Age and Ageing
online. The mean eFI score was 0.14 (SD 0.09). The 99th
centile eFI score was 0.49. Therefore, patients with an eFI
score of 0–0.12 were deﬁned as ﬁt; >0.12–0.24 as having
mild frailty; >0.24–0.36 as moderate frailty and >0.36 as
severe frailty. Estimates of prevalence for these categories
were 50, 35, 12 and 3%, respectively.
Internal validation cohort
Prevalence estimates for older people deﬁned as ﬁt, mild
frailty, moderate frailty, and severe frailty were consistent with
the development cohort at 50, 35, 12 and 3%.
Risk of mortality, unplanned hospitalisation and nursing
home admission increased for those with mild, moderate
and severe frailty at 1, 3 and 5 years, compared with ﬁt older
people (Table 2). Mortality data are also presented in a
Kaplan–Meier survival curve (Figure 1). At any age, those
with increasing frailty had lower mean life expectancy
(Figure 2).
Absolute numbers and percentages of the population ex-
periencing outcomes of mortality, unplanned hospitalisation
and nursing home admission for older people characterised
as ﬁt, mild, moderate and severe frailty are presented in
Supplementary data, Table S2, available in Age and Ageing
online.
The eFI demonstrated good discrimination for the out-
comes of mortality and nursing home admission, and mod-
erate discrimination for the outcome of hospitalisation
(Table 3). c Statistic estimates for these outcomes at 12
months were 0.72, 0.74 and 0.66, respectively. Pseudo-R2
estimates of calibration were low for all outcomes (Table 3).
External validation cohort
The CTV3 codes were mapped to 36 deﬁcits containing
1,574 corresponding Read 2 codes (Box 1). The prevalence
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Table 2. Unadjusted and adjusted 1, 3 and 5 year hazard ratios for outcomes of mortality, unplanned hospitalisation and
nursing home admission for older people with mild, moderate and severe frailty
Outcome Internal validation cohort External validation cohort
Mild frailty Moderate frailty Severe frailty Mild frailty Moderate frailty Severe frailty
1 Year mortality HR (95% CI)
Unadjusted 2.71 (2.56–2.88) 5.87 (5.51–6.24) 10.28 (9.50–11.12) 2.55 (2.44–2.66) 5.30 (5.07–5.54) 9.36 (8.88–9.87)
Adjusted 1.92 (1.81–2.04) 3.10 (2.91–3.31) 4.52 (4.16–4.91) 1.86 (1.78–1.95) 3.02 (2.88–3.16) 4.50 (4.26–4.76)
3 Year mortality HR (95% CI)
Unadjusted 2.49 (2.41–2.57) 5.20 (5.02–5.39) 9.01 (8.60–9.45) 2.34 (2.29–2.40) 4.69 (4.58–4.82) 8.35 (8.09–8.61)
Adjusted 1.77 (1.71–1.83) 2.78 (2.68–2.89) 3.99 (3.79–4.20) 1.73 (1.68–1.77) 2.70 (2.63–2.77) 4.06 (3.93–4.19)
5 Year mortality HR (95% CI)
Unadjusted 2.40 (2.34–2.46) 4.88 (4.75–5.02) 8.57 (8.25–8.91) 2.23 (2.19–2.27) 4.36 (4.28–4.45) 7.75 (7.55–7.94)
Adjusted 1.72 (1.68–1.77) 2.64 (2.57–2.72) 3.83 (3.68–3.99) 1.66 (1.63–1.69) 2.54 (2.49–2.60) 3.84 (3.74–3.94)
1 Year unplanned hospitalisation HR (95% CI)
Unadjusted 2.08 (2.00–2.16) 3.50 (3.35–3.66) 5.73 (5.38–6.10) 2.35 (2.28–2.43) 4.65 (4.49–4.81) 8.10 (7.77–8.45)
Adjusted 1.93 (1.86–2.01) 3.04 (2.90–3.19) 4.73 (4.43–5.06) 2.03 (1.96–2.10) 3.50 (3.38–3.63) 5.58 (5.34–5.84)
3 Year unplanned hospitalisation HR (95% CI)
Unadjusted 1.94 (1.90–1.98) 3.10 (3.01–3.18) 4.69 (4.50–4.90) 2.20 (2.16–2.25) 4.07 (3.98–4.16) 6.89 (6.69–7.10)
Adjusted 1.78 (1.74–1.82) 2.63 (2.55–2.71) 3.76 (3.60–3.94) 1.89 (1.85–1.93) 3.03 (2.96–3.11) 4.66 (4.51–4.80)
5 Year unplanned hospitalisation HR (95% CI)
Unadjusted 1.87 (1.84–1.90) 2.98 (2.91–3.04) 4.36 (4.20–4.53)
Adjusted 1.71 (1.68–1.74) 2.50 (2.44–2.56) 3.43 (3.31–3.58)
1 Year nursing home admission HR (95% CI)
Unadjusted 3.11 (2.69–3.59) 7.85 (6.76–9.12) 15.43 (12.84–18.56)
Adjusted 1.89 (1.63–2.15) 3.19 (2.73–3.73) 4.76 (3.92–5.77)
3 Year nursing home admission HR (95% CI)
Unadjusted 2.75 (2.56–2.95) 6.39 (5.92–6.90) 11.62 (10.48–12.89)
Adjusted 1.67 (1.56–1.80) 2.60 (2.40–2.82) 3.55 (3.19–3.96)
5 Year nursing home admission HR (95% CI)
Unadjusted 2.54 (2.42–2.67) 5.44 (5.16–5.75) 9.79 (9.06–10.58)
Adjusted 1.59 (1.51–1.67) 2.30 (2.18–2.44) 3.12 (2.88–3.38)
For all outcomes the comparator is fit older people. All data adjusted for age and sex.
HR, hazard ratio; CI, confidence interval.
NB: Hospitalisation outcome for external validation cohort includes only those practices (n= 158) with HES linked data.
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of individual deﬁcits is presented in Supplementary data,
Table S2, available in Age and Ageing online. The mean eFI
score was 0.15 (SD 0.10). The 99th centile eFI score was
0.42. Prevalence estimates for ﬁt, mild, moderate and severe
using the cut-points determined in the development cohort
were 43, 37, 16 and 4%, respectively.
Risk of mortality and hospitalisation increased for those
with mild, moderate and severe frailty (Table 2). Emergency
admission rates per 1,000 person-years at risk increased from
90.1 (95% CI 90.0–91.1) for those identiﬁed as ﬁt; 211.3
(95% CI 209.5–213.1) for those with mild frailty; 407.3 (95%
CI 403.3–411.4) for those with moderate frailty; and 706.7
(95% CI 696.1–717.3) for those with severe frailty. The
mean number of bed-days per emergency admission
increased from 9.0 (SD 19.1) for those identiﬁed as ﬁt; 9.6
(SD 17.4) for those with mild frailty; 10.3 (SD 16.5) for
those with moderate frailty; and 11.1 (SD 18.5) for those
with severe frailty (Supplementary data, Table S3, available in
Age and Ageing online).
c Statistic estimates for 12-month mortality and hospital-
isation were 0.76 and 0.71, respectively (Table 3). Pseudo-R2
estimates of calibration were low for all outcomes (Table 3).
Discussion
We have developed, internally validated and externally vali-
dated the eFI using routinely collected EHR data from over
900,000 older people in the UK using GP records contained
in two large, independent, representative primary care data-
bases. We have applied a well-established theoretical frame-
work of frailty and followed international guidelines to
develop and validate our model.
The primary aim of the eFI is to identify categories of
frailty, so the assessment of utility should be based primarily
on the predictive validity of frailty categories for adverse out-
comes. We constructed categories of ﬁt, mild, moderate and
severe frailty, and these categories identify older people at
increased risk of mortality, hospitalisation and nursing home
admission at 1, 3 and 5 years. Estimates of predictive validity
obtained from the internal validation cohort were broadly
similar to those obtained following external validation in an
independent dataset.
Implementation of the eFI into routine primary care prac-
tice could represent a major advance in the care of older
people with frailty, through provision of more appropriate,
goal-orientated care, referral for evidence-based interven-
tions and signposting to local authority and voluntary ser-
vices. Following implementation into the SystmOne EHR,
we have established a frailty collaborative to develop and
evaluate new models of primary care for older people with
Figure 2. Relationship between age, electronic frailty index
score and mortality (internal validation cohort).
Figure 1. Five-year Kaplan–Meier survival curve for the
outcome of mortality for categories of ﬁt, mild frailty, moderate
frailty and severe frailty (internal validation cohort).
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Table 3. c Statistic and pseudo-R2 estimates for the outcomes of mortality, unplanned hospitalisation, and nursing home admission
Outcome Internal validation cohort External validation cohort
1 Year 3 Year 5 Year 1 Year 3 Year 5 Year
C R2 C R2 C R2 C R2 C R2 C R2
Mortality 0.72 0.04 0.70 0.06 0.69 0.09 0.76 0.02 0.75 0.02 0.75 0.02
Emergency hospitalisation 0.66 0.03 0.64 0.05 0.63 0.06 0.71 0.02 0.69 0.02
Nursing home admission 0.74 0.04 0.72 0.04 0.70 0.04
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frailty as part of the Yorkshire and Humber Academic
Health Science Network Improvement Academy [23].
Routine identiﬁcation of frailty in primary care using the
eFI could also result in improvements in secondary care and
specialist services, for example cancer services [24]. Further
investigation of the utility of the eFI in these different set-
tings will help guide improvements in care.
Strengths of the study
We followed published standard rules for the development
and validation of a cumulative deﬁcit FI based on primary
care EHR data. Two independent researchers hand searched
all potential Read codes for inclusion to reduce the risk of
missing potentially relevant codes. The study made use of
routine coded clinical data, which means that the index can
be readily incorporated into clinical computer systems, auto-
matically populated, and made available for use in clinical
practice with no additional clinical resource required.
The eFI has robust predictive validity and good discrim-
ination for nursing home admission, hospitalisation and
mortality. These outcomes are of particular importance for
older people and health and social care systems international-
ly, and the predictive validity and discrimination characteris-
tics of the eFI across all three outcomes adds considerable
weight to the clinical utility of the tool in terms of individual
and population health planning.
A key strength of the research is that the eFI codes were
translated from CTV3 to Read 2 for the external validation.
These codes can be mapped to primary care coding schemes
that are used in other countries, which means that the eFI
has potential for future international implementation. The
successful mapping process, closely aligned baseline charac-
teristics and similar estimates for adverse outcomes obtained
in the ResearchOne and THIN cohorts, provides conﬁdence
that the eFI may have potential for international implementa-
tion following further validation.
Limitations of the study
There are a number of important limitations. There was evi-
dence of good discrimination for the outcomes of mortality,
nursing home admission and hospitalisation using linked
HES data, but calibration scores were low, indicating that the
eFI did not explain variability in these outcomes. However,
the primary aim was to apply an internationally established
model to develop a FI using routine primary care data and to
establish frailty categories with predictive validity for adverse
outcomes. Our a priori methodological approach that
assigned equal weighting to each variable is consistent with
the recognition that, in frailty, the absolute predicted risk is
of primary clinical interest [25]. A methodological approach
inconsistent with the cumulative deﬁcit model of frailty
would have been required if the primary aim had been to
develop a model that prioritised discrimination and calibra-
tion. Even in light of these considerations, estimates for dis-
crimination for outcomes of mortality and nursing home
admission were similar to estimates reported from large epi-
demiological studies using research standard cumulative
deﬁcit models [18].
THIN has routine HES linkage available for a proportion of
practices, which is considered the most reliable method of iden-
tifying unplanned hospitalisation. ResearchOne does not have
routine HES linkage, so we used coded evidence of unplanned
hospitalisation, which has been used in previous studies [26].
The differences in estimates for hospitalisation for those with
mild, moderate and severe frailty in the ResearchOne and
THIN cohorts may be a result of the methods used for identi-
fying hospitalisation in the two cohorts.
We deﬁned cut-points for estimation of frailty categories
using population quartiles. Establishing construct validity of
the eFI by comparison to a research standard FI would
enable calibration of frailty categories but would require data
linkage to large epidemiological studies and was beyond the
scope of this study.
Conclusion
We have developed and externally validated an eFI using data
from over 900,000 UK primary care patients. The eFI can be
automatically populated with routinely collected primary care
EHR data. Although the eFI has been developed and vali-
dated using UK data, it has potential for mapping to inter-
national standard coding systems. The eFI enables
identiﬁcation of older people who are ﬁt, and those with
mild, moderate and severe frailty. Using the eFI, increasing
severity of frailty identiﬁes older people who are at increased
risk of future nursing home admission, hospitalisation,
longer length of hospital stay, and mortality.
These outcomes are of key importance for older people,
their families and health and social care systems internationally.
Implementation of the eFI in routine primary care could
Box 1. List of 36 deficits contained in the
eFI.
Activity limitation Memory and cognitive problems
Anaemia and haematinic deficiency Mobility and transfer problems
Arthritis Osteoporosis
Atrial fibrillation Parkinsonism and tremor
Cerebrovascular disease Peptic ulcer
Chronic kidney disease Peripheral vascular disease
Diabetes Polypharmacy
Dizziness Requirement for care
Dyspnoea Respiratory disease
Falls Skin ulcer
Foot problems Sleep disturbance
Fragility fracture Social vulnerability
Hearing impairment Thyroid disease
Heart failure Urinary incontinence
Heart valve disease Urinary system disease
Housebound Visual impairment
Hypertension Weight loss and anorexia
Hypotension/syncope
Ischaemic heart disease
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enable better targeting of evidence-based interventions, improve
planning of health services utilisation and facilitate the devel-
opment of more appropriate, proactive, goal-orientated care
for older people with frailty.
Key points
• International guidelines recommend routine identiﬁcation
of frailty.
• Currently available tools require additional resource and
may be inaccurate.
• We have developed and externally validated an eFI using
routine primary care data.
• The eFI has robust predictive validity for outcomes of
nursing home admission, hospitalisation and mortality.
• Routine implementation of the eFI could enable delivery of
evidence-based interventions to modify frailty trajectories.
Supplementary data
Supplementary data mentioned in the text is available to
subscribers in Age and Ageing online.
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Abstract
Objectives: to examine the associations of two common CRP gene polymorphisms with CRP levels, frailty and co-morbidity
in an elderly Chinese population.
Design: a population-based cohort study.
Setting and participants: we obtained data on 1,723 elderly participants aged 70–84 from the ageing arm of the Rugao Longevity
and Ageing study (RuLAS), a population-based observational cohort study conducted in Rugao, Jiangsu province, China.
Measurements: the genotyping of two common CRP gene polymorphisms (rs1205 and rs3093059) was performed. Items con-
cerning the frailty index and co-morbidity were collected.
Results: the mean age of the study population was 75.3 ± 3.9 years, and 53.5% (n= 922) were women. The minor allele frequencies
of rs1205 and rs3093059 were 42.4% (C allele) and 16.9% (C allele), respectively. The polymorphisms rs1205 and rs3093059 were
†These authors contributed equally to this work.
360
Z.-Y. Liu et al.
Downloaded from https://academic.oup.com/ageing/article-abstract/45/3/353/1739750
by University of Leeds user
on 06 August 2018
